Similar articles for PMID: 18653811

Year	Number of Results
2005	4
2006	5
2007	5
2008	13
2009	13
2010	12
2011	13
2012	6
2013	12
2014	8
2015	7
2016	7
2017	6
2018	6
2019	5
2020	7
2021	8
2022	4
2023	1
2024	0

1

Tocilizumab: the first interleukin-6-receptor inhibitor.

Sebba A. Sebba A. Am J Health Syst Pharm. 2008 Aug 1;65(15):1413-8. doi: 10.2146/ajhp070449. Am J Health Syst Pharm. 2008. PMID: 18653811 Review.

2

Clinical value of blocking IL-6 receptor.

Mima T, Nishimoto N. Mima T, et al. Curr Opin Rheumatol. 2009 May;21(3):224-30. doi: 10.1097/BOR.0b013e3283295fec. Curr Opin Rheumatol. 2009. PMID: 19365268 Review.

3

Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate.

Maini RN, Taylor PC, Szechinski J, Pavelka K, Bröll J, Balint G, Emery P, Raemen F, Petersen J, Smolen J, Thomson D, Kishimoto T; CHARISMA Study Group. Maini RN, et al. Arthritis Rheum. 2006 Sep;54(9):2817-29. doi: 10.1002/art.22033. Arthritis Rheum. 2006. PMID: 16947782 Free article. Clinical Trial.

4

Tocilizumab: an interleukin-6 receptor inhibitor for the treatment of rheumatoid arthritis.

Plushner SL. Plushner SL. Ann Pharmacother. 2008 Nov;42(11):1660-8. doi: 10.1345/aph.1L268. Epub 2008 Oct 28. Ann Pharmacother. 2008. PMID: 18957621 Review.

5

Profile of sarilumab and its potential in the treatment of rheumatoid arthritis.

Raimondo MG, Biggioggero M, Crotti C, Becciolini A, Favalli EG. Raimondo MG, et al. Drug Des Devel Ther. 2017 May 24;11:1593-1603. doi: 10.2147/DDDT.S100302. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28579757 Free PMC article. Review.

6

Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy.

Nishimoto N, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Azuma J, Kishimoto T. Nishimoto N, et al. Mod Rheumatol. 2009;19(1):12-9. doi: 10.1007/s10165-008-0125-1. Epub 2008 Nov 1. Mod Rheumatol. 2009. PMID: 18979150 Free PMC article. Clinical Trial.

7

Will treatment of rheumatoid arthritis with an IL-6R inhibitor help facilitate the 'age of remission'?

Moots RJ, Ostör AJ, Isaacs JD. Moots RJ, et al. Expert Opin Investig Drugs. 2009 Nov;18(11):1687-99. doi: 10.1517/14728220903185939. Expert Opin Investig Drugs. 2009. PMID: 19715449 Review.

8

Tocilizumab for the treatment of rheumatoid arthritis.

Tanaka T, Ogata A, Narazaki M. Tanaka T, et al. Expert Rev Clin Immunol. 2010 Nov;6(6):843-54. doi: 10.1586/eci.10.70. Expert Rev Clin Immunol. 2010. PMID: 20979549 Review.

9

Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy.

Snir A, Kessel A, Haj T, Rosner I, Slobodin G, Toubi E. Snir A, et al. Clin Exp Rheumatol. 2011 Jul-Aug;29(4):697-700. Epub 2011 Sep 1. Clin Exp Rheumatol. 2011. PMID: 21813064

10

[IL-6 blockade].

Kaneko Y, Takeuchi T. Kaneko Y, et al. Nihon Rinsho. 2016 Jun;74(6):963-7. Nihon Rinsho. 2016. PMID: 27311186 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

131 results

Results by year